Pfizer-BioNTech Omicron-specific vaccine delayed, but might not be needed

Portfolio
Delivery of Pfizer and BioNTech SE's vaccine to combat the Omicron COVID-19 variant was delayed by several weeks due to a slower-than-expected data gathering process, BionTech Chief Executive Ugur Sahin told Germany's Bild on Thursday, Reuters reported.

Once the vaccine is ready, the company would assess whether it was still needed, Sahin said.

"If the wave ends, that does not mean it can't begin again," he told Bild in a video interview, adding that BioNTech was in a position to continue creating new vaccines as variants emerged if needed.

I really don't see the situation as dramatic anymore,

he said, referring to how the coronavirus would develop in future.

BioNTech had previously expected to launch the vaccine by end of March, but said in late January that this depended on how much clinical data regulators would require.

 

More in Business

idegenforgalom-nyár-nyaralás-strand-tenger-turista-turizmus-utazás-üdülő
July 11, 2025 08:00

Hungarian travel agency Unitravel goes bankrupt, authority decides on compensation

Settlements for passengers can begin

July 08, 2025 11:04

3% loan scheme could provide significant support for home buyers in Hungary

Duna House publishes Q2 figures

July 04, 2025 08:55

French air traffic controllers' strike affects Wizz Air flights

Tens of thousands of travellers are affected

catl
July 03, 2025 12:33

CATL responds to press reports: No layoffs at Debrecen plant

They have even added to staff

July 01, 2025 12:45

Richter receives EC approval for bone health products

A milestone for the company

LATEST NEWS

Detailed search